Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alexander M Walker, Lisa B Weatherby, M Soledad Cepeda & Daniel C Bradford. (2019)
Information on doctor and pharmacy shopping for opioids adds little to the identification of presumptive opioid abuse disorders in health insurance claims data. Substance Abuse and Rehabilitation 10, pages 47-55.
Read now
Read now
Articles from other publishers (11)
Jennifer McNeely, Shane D. Gallagher, Medha Mazumdar, Noa Appleton, Jasmine Fernando, Elizabeth Owens, Emmeline Bone, Noa Krawczyk, Johanna Dolle, Roopa Kalyanaraman Marcello, John Billings & Scarlett Wang. (2023) Sensitivity of Medicaid Claims Data for Identifying Opioid Use Disorder in Patients Admitted to 6 New York City Public Hospitals. Journal of Addiction Medicine 17:3, pages 339-341.
Crossref
Crossref
Salva N Balbale, Lishan Cao, Itishree Trivedi, Jonah J Stulberg, Katie J Suda, Walid F Gellad, Charlesnika T Evans, Neil Jordan, Laurie A Keefer & Bruce L Lambert. (2022) Opioid-related emergency department visits and hospitalizations among patients with chronic gastrointestinal symptoms and disorders dually enrolled in the Department of Veterans Affairs and Medicare Part D. American Journal of Health-System Pharmacy 79:2, pages 78-93.
Crossref
Crossref
Vivienne J Zhu, Leslie A Lenert, Kelly S Barth, Kit N Simpson, Hong Li, Michael Kopscik & Kathleen T Brady. (2022) Automatically identifying opioid use disorder in non-cancer patients on chronic opioid therapy. Health Informatics Journal 28:2, pages 146045822211078.
Crossref
Crossref
Daniel C. Beachler, Kelsey Hall, Renu Garg, Geetanjoli Banerjee, Ling Li, Luke Boulanger, Huseyin Yuce & Alexander M. Walker. (2022) An Evaluation of the Effect of the OxyContin Reformulation on Unintentional Fatal and Nonfatal Overdose. The Clinical Journal of Pain 38:6, pages 396-404.
Crossref
Crossref
Pooja Lagisetty, Claire Garpestad, Angela Larkin, Colin Macleod, Derek Antoku, Stephanie Slat, Jennifer Thomas, Victoria Powell, Amy S.B. Bohnert & Lewei A. Lin. (2021) Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug and Alcohol Dependence 221, pages 108583.
Crossref
Crossref
Jørgen G. Bramness. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment
325
342
.
Vwaire Orhurhu, Mayowa OlusunmadeIvan UritsOmar ViswanathJacquelin PeckMariam Salisu OrhurhuPeju AdekoyaSameer HirjiJohn SampsonThomas SimopoulosGill Jatinder. (2019) Trends of Opioid Use Disorder Among Hospitalized Patients With Chronic Pain. Pain Practice 19:6, pages 656-663.
Crossref
Crossref
Carsten Buhmann, Tina Mainka, Georg Ebersbach & Florin Gandor. (2019) Evidence for the use of cannabinoids in Parkinson’s disease. Journal of Neural Transmission 126:7, pages 913-924.
Crossref
Crossref
Carl L. RolandXiangyang YeVanessa StevensGary M. Oderda. (2019) The Prevalence and Cost of Medicare Beneficiaries Diagnosed and At Risk for Opioid Abuse, Dependence, and Poisoning. Journal of Managed Care & Specialty Pharmacy 25:1, pages 18-27.
Crossref
Crossref
Jessica C. Young, Jennifer L. Lund, Nabarun Dasgupta & Michele Jonsson Funk. (2019) Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids. Pharmacoepidemiology and Drug Safety 28:1, pages 39-47.
Crossref
Crossref
Amit Garg, Vassiliki Papagermanos, Margaretta Midura, Andrew Strunk & Jonathan Merson. (2018) Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States. Journal of the American Academy of Dermatology 79:3, pages 495-500.e1.
Crossref
Crossref